Abstract:The chromium(III) complex, Cr(C7H3NO4)2·C4H12N5 (1), was synthesised by chelating chromium with dipicolinic (H2dipic) in methanol, and its structure was characterised using elemental analysis (EA), spectroscopy (infrared, UV–visible, and fluorescence) and single-crystal X-ray method. The density functional theoretical (DFT) computation was performed using the Gaussian 09 package. The stability of solution at different temperatures and pH values, the electrochemical, morphological and thermal properties of complex 1 were discussed. The preliminary bioactivities of complex 1 in streptozotocin (STZ)-induced type 2 diabetes mellitus (T2DM) mice were investigated using daily oral gavage for 12 weeks. The cytotoxicity was assessed using the methyl thiazolyl tetrazolium (MTT) assays, and the acute toxicity experiment test was carried out on healthy C57BL/6 mice with this complex. The complex 1 crystallised in the monoclinic system with the space group P2(1)/n, R1 = 0.0642. The DFT-optimised structure of complex 1 was in excellent agreement with the X-ray crystal structure. The complex 1 exhibited good physical and chemical properties and beneficial function on blood glucose and lipid metabolism for T2DM. The antidiabetic activity of chromium(III) might be associated with chromium(VI). Furthermore, the cytotoxicity and the acute toxicity experiments showed that the complex 1 was hypotonic and secure to organism. The study of complex 1 showed that the prepared complex on the basis of H2dipic and Met could inhibit hyperglycaemia and hyperlipidaemia in vivo and did not have potential toxicity. These results demonstrated that the complex 1 might provide an important reference for the development of functional hypoglycaemic foods or pharmaceuticals of T2DM.

Synthesis and Characterization of Baicalin-Chromium(Ⅲ) Complex

Synthesis and characterization of baicalin-chromium (III) complex

Evaluation of Hypoglycemic Activity and Sub-Acute Toxicity of the Novel Biochanin A-Chromium(III) Complex

Research on Synthesis and Biological Activities of Baicalin-La( Ⅲ)、Y(Ⅲ) Complexes

Synthesis of Baicalin-Copper and Baicalin-Aluminium Complex and Its Bioactivity

Chromium(Iii) Complexes of D-Glucosaminic Acid and Their Effect on Decreasing Blood Sugar in Vivo

Stability of baicalin in biological fluids in vitro.

Preparation of a Novel Oat β-Glucan–Chromium(III) Complex and Its Hypoglycemic Effect and Mechanism

Potential antidiabetic molecule involving a new chromium(III) complex of dipicolinic and metformin as a counter ion: Synthesis, structure, spectroscopy, and bioactivity in mice

Supramolecular interaction between berberine hydrochloride and baicalin in aqueous solution: Reaction kinetics, spectral analysis and dynamic simulation

[Preparation of Baicalin-Chitooligosaccharide Compound and Its Characterization].

Preparation of a hydrolyzed yeast β-glucan chromium(III) complex and evaluation of its hypoglycemic activity and sub-acute toxicity

Complexation of Baicalin with Ferrous (II) and Its Characterization

Synthesis and characterization of the chromium(Ⅲ) complexes with rutin and quercetin

Efficient Synthesis of Baicalin and Its Analogs

Preparation Technology of Baicalin Nanocrystallines

Synthesis, crystal structure, and interaction with DNA and BSA of a chromium(III) complex with naph-gly Schiff base and 1,10-phenanthroline

Synthesis of Sulfonated Baicalein and Its Antioxidative Activity and Interaction with DNA

Baicalin-berberine complex nanocrystals orally promote the co-absorption of two components

A Newly Synthetic Chromium Complex – Chromium(phenylalanine)3 Improves Insulin Responsiveness and Reduces Whole Body Glucose Tolerance

Characterization and Evaluation in Vivo of Baicalin-Nanocrystals Prepared by an Ultrasonic-Homogenization-fluid Bed Drying Method